Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494571 · ClinicalTrials.gov registry record
Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 101
- Enrollment target
NCT01494571: Completed study, sponsored by University of Colorado, Denver.
NCT01494571 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01494571 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The PharmaJet needle-free injection system is a consistent approach to delivering injectates into the dermal layer of the human skin for the purpose of vaccination or medication delivery.
Primary Outcome
To assess measures of injection performance, including estimates of injection completeness by collecting residual surface moisture with filter paper that will be circled with indelible ink; the volume will be compared to a reference set of moisture recordings. Measurement of the bleb size following injection will recorded in millimeters.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-09 |
What the finished NCT01494571 record still lists
NCT01494571 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01494571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01494571 about?
NCT01494571 is a clinical study titled "Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System". The PharmaJet needle-free injection system is a consistent approach to delivering injectates into the dermal layer of the human skin for the purpose of vaccination or medication delivery.
What is the current status of trial NCT01494571?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2011-12. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01494571?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia